MOSAIQUES DIAGNOSTICS GMBH
Desconocido
Showing
1
to
20
of
40
results
PROMOTE: PRostate cancer OMics Oriented inTErvention
MOSAIQUES DIAGNOSTICS GMBH
tramitó un
HORIZON EUROPE:
HORIZON-MSCA-2023-DN-01
PROMOTE focuses on multidisciplinary education of doctoral candidates (DCs) in -omics and artificial intelligence (AI) mediated intervention...
2024-09-01 - 2028-08-31 | Financiado
2024-09-01 - 2028-08-31 | Financiado
PICKED: PersonalIzed medicine in Chronic KidnEy Disease
MOSAIQUES DIAGNOSTICS GMBH
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2023-DN-01
In 2017, on a world scale the total number of individuals with chronic kidney disease, acute kidney injury, and those on renal replacement t...
2024-06-26 - 2028-09-30 | Financiado
2024-06-26 - 2028-09-30 | Financiado
PROMOTE: PRostate cancer OMics Oriented inTErvention
PROMOTE focuses on multidisciplinary education of doctoral candidates (DCs) in -omics and artificial intelligence (AI) mediated intervention...
2024-06-24 - 2028-08-31 | Financiado
2024-06-24 - 2028-08-31 | Financiado
ReDrugBC: Novel therapeutic approaches based on drug repurposing for high risk non muscle invasive bladder c...
MOSAIQUES DIAGNOSTICS GMBH
tramitó un
H2020:
H2020-MSCA-IF-2019
Bladder Cancer (BC) is the costlier cancer type to manage, characterized by high recurrence and progression rates. Despite recent advancemen...
2020-03-26 - 2022-05-31 | Financiado
2020-03-26 - 2022-05-31 | Financiado
STRATEGY-CKD: System omics to unravel the gut kidney axis in Chronic Kidney Disease.
MOSAIQUES DIAGNOSTICS GMBH
participó en un
H2020:
H2020-MSCA-ITN-2019
System omics to unravel the gut-kidney axis in Chronic Kidney Disease:
There is a great need for multi-disciplinary and methodologically wel...
2020-02-05 - 2024-07-31 | Financiado
2020-02-05 - 2024-07-31 | Financiado
DC-ren: Drug combinations for rewriting trajectories of renal pathologies in type II diabetes DC ren
MOSAIQUES DIAGNOSTICS GMBH
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Diabetic Kidney Disease (DKD) is highly prevalent in type 2 diabetes, with major impact on patients and healthcare systems. The complex diso...
2019-12-13 - 2024-12-31 | Financiado
2019-12-13 - 2024-12-31 | Financiado
PROCEED: Proteomics for Chronic Kidney Disease Therapy
MOSAIQUES DIAGNOSTICS GMBH
tramitó un
H2020:
H2020-MSCA-IF-2017
The social and financial burden that chronic kidney disease (CKD) imposes on European countries is significant. Currently 16.95% of the glob...
2018-07-05 - 2021-02-28 | Financiado
2018-07-05 - 2021-02-28 | Financiado
PCaProTreat: Multi omics molecular treatment targets for Prostate Cancer
MOSAIQUES DIAGNOSTICS GMBH
tramitó un
H2020:
H2020-MSCA-IF-2017
The PCaProTreat Project targets on improving the Prostate Cancer (PCa) management and focuses on the identification of novel therapeutic tar...
2018-03-15 - 2020-03-31 | Financiado
2018-03-15 - 2020-03-31 | Financiado
CaReSyAn: Combatting the CardioRenal Syndrome towards an integrative Analysis to reduce cardiovascular burden...
MOSAIQUES DIAGNOSTICS GMBH
participó en un
H2020:
H2020-MSCA-ITN-2017
Successfully combatting a complex disease requires multi-disciplinary and methodically well-trained scientists. CaReSyAn strives to accompli...
2017-08-10 - 2021-12-31 | Financiado
2017-08-10 - 2021-12-31 | Financiado
BioMedBC: Molecular profiling of Bladder Cancer to support personalized medicine
MOSAIQUES DIAGNOSTICS GMBH
tramitó un
H2020:
H2020-MSCA-IF-2016
BioMedBC Proposal is focused on improving the patient management of Bladder Cancer (BC). BC presents with the highest recurrence rate and th...
2017-03-03 - 2019-03-31 | Financiado
2017-03-03 - 2019-03-31 | Financiado
TheranOMICS: Integration of high resolution OMICS datasets towards personalized therapy in bladder cancer
MOSAIQUES DIAGNOSTICS GMBH
tramitó un
H2020:
H2020-INNOSUP-2016-2017
"TheranOMICS Project aims at the recruitment of a highly-qualified research Associate to support the Innovation Business Idea of Mosaiques d...
2017-02-28 - 2018-09-28 | Financiado
2017-02-28 - 2018-09-28 | Financiado
TransPot: Translational Research Network in Prostate Cancer
MOSAIQUES DIAGNOSTICS GMBH
participó en un
H2020:
H2020-MSCA-ITN-2016
The Translational Research Network for Prostate Cancer (TransPot) program adopts an innovative, multidisciplinary approach, providing highly...
2016-08-16 - 2021-04-30 | Financiado
2016-08-16 - 2021-04-30 | Financiado
PRETREAT: PRoteome based assessment of vascular disease for the Establishment of a Translational REsearch plAT...
MOSAIQUES DIAGNOSTICS GMBH
participó en un
H2020:
H2020-MSCA-RISE-2015
Cardiovascular disease (VD) is the leading cause of mortality and morbidity in Europe and worldwide. The objective of the PRETREAT consortiu...
2015-10-13 - 2019-12-31 | Financiado
2015-10-13 - 2019-12-31 | Financiado
RENALTRACT: Development and disease of the renal tract
MOSAIQUES DIAGNOSTICS GMBH
participó en un
H2020:
H2020-MSCA-ITN-2014
The renal tract (kidneys, the ureters, bladder) is a complex organ system crucial for maintaining the body homeostasis. This organ system ar...
2015-06-04 - 2019-05-31 | Financiado
2015-06-04 - 2019-05-31 | Financiado
Chromatin3D: Chromatin Dynamics in Development and Disease
MOSAIQUES DIAGNOSTICS GMBH
participó en un
H2020:
H2020-MSCA-ITN-2014
The cell nucleus is organized and compartmentalized into a highly ordered structure that contains DNA, RNA, chromosomal and histone proteins...
2014-12-12 - 2018-12-31 | Financiado
2014-12-12 - 2018-12-31 | Financiado
* No se disponen de datos de la empresa actual.